PTC Therapeutics | PTCT - Ebitda



PTC Therapeutics reported $971.14M in EBITDA for its fiscal quarter ending in March of 2025.


Ebitda Change Date
Acadia Pharmaceuticals USD 35.31M 13.07M Jun/2025
Alnylam Pharmaceuticals USD 18.83M 13.65M Jun/2025
Amgen USD 3.6B 147M Jun/2025
Biogen USD 1.01B 456.5M Jun/2025
BioMarin Pharmaceutical USD 295.45M 49.49M Jun/2025
Cytokinetics USD -153331000 16.67M Mar/2025
Daiichi Sankyo JPY 101.6B 22.81B Mar/2025
Gilead Sciences USD 3.4B 797M Jun/2025
Incyte USD 581.52M 358.87M Jun/2025
Ionis Pharmaceuticals USD 150.23M 291.7M Jun/2025
Ironwood Pharmaceuticals USD 32.05M 5.89M Dec/2024
Novartis USD 6.17B 339M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
PTC Therapeutics USD 971.14M 970.07M Mar/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sarepta Therapeutics USD 126.42M 416.82M Jun/2025
TG Therapeutics USD 12.28M 17.68M Mar/2025
Ultragenyx Pharmaceutical USD -91344000 35.09M Jun/2025
Vertex Pharmaceuticals USD 1.34B 556.6M Jun/2025
Xencor USD -30519000 6.39M Jun/2025